Regenevida, Inc. — Form D
Regenevida, Inc. of St. Paul, MN, a company, filed a Form D exempt-offering notice with the SEC on 2018-09-06. The offering totals $23.6M, of which $7K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-09-06
- Form: D
- Accession: 0001209191-18-049890
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $23.6M
- Amount sold: $7K
- Remaining: $23.5M
- Investors: 2
- Date of first sale: 2018-08-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-320800
Issuer
- Name: Regenevida, Inc.
- CIK: 0001736337
- Entity type: Corporation
- Jurisdiction: MINNESOTA
- Incorporated: 2013
- Address: 1246 University Avenue West, St. Paul, MN, 55104
- Phone: 612-727-2000
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Scott Fahrenkrug | Director | St. Paul, MN |
| John F Cameron | Executive Officer | St. Paul, MN |
| Scott Fahrenkrug | Executive Officer | St. Paul, MN |
| Walter F Low | Executive Officer | St. Paul, MN |
| Justin F Zenanko | Executive Officer | St. Paul, MN |
More